Market Access Views & Analysis

Views & Analysis

Pharma’s response to COVID: GSK

A few months into the pandemic, the world is now moving beyond managing the crisis, with more focus on addressing the collateral damages and shaping the future.

Views & Analysis

Why intelligent automation is the future for regulation

Why intelligent automation is the future for regulatory

There are a host of new, previously unimaginable tools and techniques – from analytics to robotic process automation (RPA) and artificial intelligence (AI) – available to help speed up proc

Views & Analysis

Life science leaders sign new ‘Biotech Social Pact’ for Euro...

The signatories of a new Biotech Social Pact with Europe and p

Views & Analysis

A history of AstraZeneca

A look back at AstraZeneca and its roots in the UK and Sweden

White Papers

Preparing for a decade of radical change in pharma

Transformational value - preparing for a decade of radical c...

The pharmaceutical industry is at an inflection point, where ground-breaking innovation must be translated into transformational value for patients, healthcare professionals and society.

Views & Analysis

Unpleasant truth: the pandemic, record debt and our opportun...

Sandoz’s Pierre Bourdage looks at the unexpected secondary impacts of COVID-19 on countries and healthcare systems, and asks how pharma can help improve sustainability to tackle them.

Pharma’s response to COVID: GSK

Why intelligent automation is the future for regulatory

Life science leaders sign new ‘Biotech Social Pact’ for Euro...

A history of AstraZeneca

Transformational value - preparing for a decade of radical c...

Unpleasant truth: the pandemic, record debt and our opportun...

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks